Mukesh Harisinghani, MD
Associate Professor of Radiology, Harvard Medical School
Assistant Radiologist, Dept. of Abdominal Imaging

Phone: 617-726-8396
Email: mharisinghani@mgh.harvard.edu

Design and conduct clinical trials and provide an avenue for clinical testing of novel imaging agents developed at CMIR.

Over the last several years we have conducted phase 1,2 and phase 3 clinical trials of monocrystalline iron oxides (1-2) for a number of applications. Current trials evaluate the efficacy of these agents to improve detection of subtle lymph node metastases in patients with prostate cancer (funded in part by RSNA) and renal cancer (funded in part by by SCBT).

My primary clinical interests lie in abdominal and pelvic MR imaging



Publications
Paly JJ, Efstathiou JA, Hedgire SS, Chung PW, O'Malley M, Shah A, Bekelman JE, Harisinghani M, Shipley WU, Zietman AL, Beard C
Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields.
Radiother Oncol. 2013;106(1):64-8 - PMID: 23321493 - Cover
Rajesh A, Cloud G, Harisinghani MG
Improving the quality of manuscript reviews: impact of introducing a structured electronic template to submit reviews.
AJR Am J Roentgenol. 2013;200(1):20-3 - PMID: 23255737
Preston MA, Harisinghani MG, Mucci L, Witiuk K, Breau RH
Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer.
BJU Int. 2013;111(3):514-7 - PMID: 23320634
Hedgire SS, Sainani NI, McDermott S, Hahn PF, Harisinghani MG
Mono-belly and beyond: spectrum of imaging manifestations of EBV infection in the abdomen.
Clin Imaging. 2013;:ePub - PMID: 23317894
4